EUVIMEDEUVIMED entdecken
Crossref

SARS-CoV-2 Vaccination Induced Pericarditis and Myocarditis

Thyyar M Ravindranath

Mathews Journal of Cardiology · 2024

DOI: 10.30654/mjc.10037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mathews Journal of Cardiology, 2024. Verfasst von Thyyar M Ravindranath.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac inflammation in the form of myopericarditis (myocarditis and pericarditis) is a well-known and rare complication of the SARS-COV-2 (COVID-19) vaccination for both the mRNA constructed as well as the Adeno viral based platforms.Myopericarditis following COVID-19 vaccination is a transient phenomenon with very low morbidity and mortality is rare.A high degree of suspicion in younger, vaccinated individuals in the appropriate clinical setting and confirmatory laboratory evaluation leads to the diagnosis.The treatment approach is based on the presence of symptoms and the outcome is excellent although the longterm outlook is unknown at present.In this brief review, the mechanism of action of mRNA and vector based COVID-19 vaccines, the proposed mechanism of pathogenesis of cardiac inflammation following COVID-19 vaccination, diagnosis, therapeutic options, and follow up of patients will be discussed.

Zitieren

APA

Ravindranath, T. M. (2024). SARS-CoV-2 Vaccination Induced Pericarditis and Myocarditis. Mathews Journal of Cardiology. https://doi.org/10.30654/mjc.10037

Vancouver

Ravindranath TM. SARS-CoV-2 Vaccination Induced Pericarditis and Myocarditis. Mathews Journal of Cardiology. 2024. doi:10.30654/mjc.10037

BibTeX
@article{Ravindranath2024,
  author = {Ravindranath, Thyyar M},
  title = {SARS-CoV-2 Vaccination Induced Pericarditis and Myocarditis},
  journal = {Mathews Journal of Cardiology},
  year = {2024},
  doi = {10.30654/mjc.10037}
}
Kostenlos starten →